Long-Term Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

被引：0
|
作者：
Rubin, David T. [1 ]
Cree, Bruce A. C. [2 ]
Wolf, Douglas C. [3 ]
Alekseeva, Olga [4 ]
Charles, Lorna [5 ]
Petersen, AnnKatrin [5 ]
Sheffield, James K. [5 ]
Cheng, Chun-Yen [5 ]
Riolo, Jon V. [5 ]
Silva, Diego [5 ]
Lublin, Fred D. [6 ]
Cohen, Jeffrey A. [7 ]
Danese, Silvio [8 ]
机构：
[1] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
[2] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA USA
[3] Atlanta Gastroenterol Associates, Ctr Crohns Dis & Ulcerat Colitis, Atlanta, GA USA
[4] Nizhny Novgorod Reg Clin Hosp, Nizhnii Novgorod, Nizhegorod, Russia
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Mt Sinai Med Ctr, New York, NY USA
[7] Cleveland Clin, Mellen Ctr MS Treatment & Res, Cleveland, OH USA
[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Milan, Lombardia, Italy
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S911
引用
下载
收藏
页码：S680 / S680
页数：1
相关论文
共 50 条
  • [41] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: interim analysis of the DAYBREAK open-label extension study
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, K.
    Hoogerheyde, J.
    Afsari, S.
    Sheffield, J. K.
    Shi, F.
    Minton, N.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 617 - 618
  • [42] Clinical remission demonstrated with oral ozanimod in the overall population and across multiple subgroups of patients with moderately to severely active ulcerative colitis in the TOUCHSTONE trial
    Feagan, B. G.
    Sandborn, W. J.
    D'Haens, G.
    Hanauer, S.
    Wolf, D. C.
    Vermeire, S.
    Ghosh, S.
    Petersen, A.
    Hua, S. Y.
    Shan, K.
    Liu, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S464 - S464
  • [43] One Fell Swoop: Ozanimod for Ulcerative Colitis and Multiple Sclerosis
    Figueroa, Gabriela
    Forster, Erin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S12 - S12
  • [44] THE EFFECT OF OZANIMOD ON CIRCULATING NEUTROPHILS: RESULTS FROM THE TRUE NORTH STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Harris, Sarah
    Wu, Chun
    Li, Yicong
    Maddux, Rachel
    Hu, Sarah
    Petersen, AnnKatrin
    GASTROENTEROLOGY, 2022, 162 (07) : S973 - S973
  • [45] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis in daybreak: an open-label extension study of ozanimod phase 1-3 trials
    Selmaj, K.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D.
    Hartung, H. P.
    Montalban, X.
    Havrdova, E.
    Sheffield, J.
    Chen, T.
    Minton, N.
    Silva, D.
    Kappos, L.
    Cohen, J.
    Cree, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 223 - 223
  • [46] Baseline Predictors of Long-Term Disability Progression in Ozanimod-Treated Participants With Relapsing Multiple Sclerosis
    Hartung, Hans-Peter
    DeLuca, John
    Granziera, Cristina
    Filippi, Massimo
    Kappos, Ludwig
    Cheng, Chun-Yen
    Pachai, Chahin
    Riolo, Jon
    DeBoer, Erik
    Silva, Diego
    Penner, Iris-Katharina
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 354 - 355
  • [47] Ulcerative colitis Sustained Effectiveness and good Tolerability with Long-term Use of Ozanimod
    不详
    VISCERAL MEDICINE, 2023, 39 (3-4) : 98 - 98
  • [48] An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis
    Fronza, Marzia
    Lorefice, Lorena
    Frau, Jessica
    Cocco, Eleonora
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1993 - 2004
  • [49] The efficacy and safety of adalimumab for patients with moderately to severely active ulcerative colitis and predictors of response in Korea
    Shin, S. Shin
    Park, S. J.
    Kim, Y.
    Im, J. P.
    Kim, H. J.
    Lee, K. M.
    Kim, J. W.
    Jung, S. A.
    Lee, J.
    Kang, S. B.
    Shin, S. J.
    Kim, E. S.
    Kim, Y. S.
    Kim, T. O.
    Kim, H. S.
    Park, D. I.
    Kim, H. K.
    Kim, E. S.
    Kim, Y. H.
    Kim, D. H.
    Teng, D.
    Kim, J. H.
    Kim, W. Y.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S432 - S432
  • [50] Incidence and outcomes of herpes zoster in the ozanimod phase, 3 ulcerative colitis and relapsing multiple sclerosis clinical program
    Siegmund, B.
    Melmed, G. Y.
    Irving, P. M.
    Pai, A.
    Patel, A.
    Sheffield, J. K.
    Caldera, F.
    Cree, B. A. C.
    Dubinsky, M. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I395 - I396
12345